Cargando…
Utility of Direct Immunofluorescence in Cutaneous Autoimmune Bullous Disorders
Background Autoimmune bullous disorders (AIBD) are a heterogeneous group of disorders with substantial clinical overlap associated with blistering of skin or mucosa. Aims The present study aimed to study the histopathological spectrum and evaluate the utility of direct immunofluorescence (DIF) on sn...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133519/ https://www.ncbi.nlm.nih.gov/pubmed/34026378 http://dx.doi.org/10.7759/cureus.14562 |
_version_ | 1783695088971415552 |
---|---|
author | Brar, Arika Sharma, Abhimanyu Nauhria, Samal Nauhria, Shreya Bhattacharjee, Aniruddha Peela, Jagannadha Joshi, Kusum |
author_facet | Brar, Arika Sharma, Abhimanyu Nauhria, Samal Nauhria, Shreya Bhattacharjee, Aniruddha Peela, Jagannadha Joshi, Kusum |
author_sort | Brar, Arika |
collection | PubMed |
description | Background Autoimmune bullous disorders (AIBD) are a heterogeneous group of disorders with substantial clinical overlap associated with blistering of skin or mucosa. Aims The present study aimed to study the histopathological spectrum and evaluate the utility of direct immunofluorescence (DIF) on snap-frozen and paraffin-embedded sections in resolving the differential diagnosis of AIBD and connective tissue disorders of the skin. We also compared the efficacy of DIF on paraffin versus the snap-frozen sections in diagnosing AIBD. Methods The present study was conducted for three years (2017-2019) and included 27 biopsies. We also included a retrospective analysis that included 25 biopsies collected over three years (2014-2017). Histopathological examination and DIF were conducted on all samples. Results Pemphigus vulgaris was the most common autoimmune cutaneous disorder constituting 37% (n = 10) in prospective and 36% (n = 9) in the retrospective study. DIF showed a specificity of 81.25% in our prospective study. While on the paraffin-embedded sections, it showed a specificity of 66.6% in our retrospective study. In the prospective study, DIF on paraffin-embedded sections had a positivity rate of 43.75% as compared to 81.25% in DIF done on snap-frozen sections. Conclusion DIF is a sensitive tool for the diagnosis as well as distinguishing immune-mediated bullous disorders from other lesions primarily when performed on snap-frozen sections. The diagnostic yield is enhanced by DIF in cases that pose a diagnostic dilemma both clinically and histologically. The final diagnosis depends on all clinical, histopathological and immunofluorescence findings. |
format | Online Article Text |
id | pubmed-8133519 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-81335192021-05-21 Utility of Direct Immunofluorescence in Cutaneous Autoimmune Bullous Disorders Brar, Arika Sharma, Abhimanyu Nauhria, Samal Nauhria, Shreya Bhattacharjee, Aniruddha Peela, Jagannadha Joshi, Kusum Cureus Dermatology Background Autoimmune bullous disorders (AIBD) are a heterogeneous group of disorders with substantial clinical overlap associated with blistering of skin or mucosa. Aims The present study aimed to study the histopathological spectrum and evaluate the utility of direct immunofluorescence (DIF) on snap-frozen and paraffin-embedded sections in resolving the differential diagnosis of AIBD and connective tissue disorders of the skin. We also compared the efficacy of DIF on paraffin versus the snap-frozen sections in diagnosing AIBD. Methods The present study was conducted for three years (2017-2019) and included 27 biopsies. We also included a retrospective analysis that included 25 biopsies collected over three years (2014-2017). Histopathological examination and DIF were conducted on all samples. Results Pemphigus vulgaris was the most common autoimmune cutaneous disorder constituting 37% (n = 10) in prospective and 36% (n = 9) in the retrospective study. DIF showed a specificity of 81.25% in our prospective study. While on the paraffin-embedded sections, it showed a specificity of 66.6% in our retrospective study. In the prospective study, DIF on paraffin-embedded sections had a positivity rate of 43.75% as compared to 81.25% in DIF done on snap-frozen sections. Conclusion DIF is a sensitive tool for the diagnosis as well as distinguishing immune-mediated bullous disorders from other lesions primarily when performed on snap-frozen sections. The diagnostic yield is enhanced by DIF in cases that pose a diagnostic dilemma both clinically and histologically. The final diagnosis depends on all clinical, histopathological and immunofluorescence findings. Cureus 2021-04-19 /pmc/articles/PMC8133519/ /pubmed/34026378 http://dx.doi.org/10.7759/cureus.14562 Text en Copyright © 2021, Brar et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Dermatology Brar, Arika Sharma, Abhimanyu Nauhria, Samal Nauhria, Shreya Bhattacharjee, Aniruddha Peela, Jagannadha Joshi, Kusum Utility of Direct Immunofluorescence in Cutaneous Autoimmune Bullous Disorders |
title | Utility of Direct Immunofluorescence in Cutaneous Autoimmune Bullous Disorders |
title_full | Utility of Direct Immunofluorescence in Cutaneous Autoimmune Bullous Disorders |
title_fullStr | Utility of Direct Immunofluorescence in Cutaneous Autoimmune Bullous Disorders |
title_full_unstemmed | Utility of Direct Immunofluorescence in Cutaneous Autoimmune Bullous Disorders |
title_short | Utility of Direct Immunofluorescence in Cutaneous Autoimmune Bullous Disorders |
title_sort | utility of direct immunofluorescence in cutaneous autoimmune bullous disorders |
topic | Dermatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133519/ https://www.ncbi.nlm.nih.gov/pubmed/34026378 http://dx.doi.org/10.7759/cureus.14562 |
work_keys_str_mv | AT brararika utilityofdirectimmunofluorescenceincutaneousautoimmunebullousdisorders AT sharmaabhimanyu utilityofdirectimmunofluorescenceincutaneousautoimmunebullousdisorders AT nauhriasamal utilityofdirectimmunofluorescenceincutaneousautoimmunebullousdisorders AT nauhriashreya utilityofdirectimmunofluorescenceincutaneousautoimmunebullousdisorders AT bhattacharjeeaniruddha utilityofdirectimmunofluorescenceincutaneousautoimmunebullousdisorders AT peelajagannadha utilityofdirectimmunofluorescenceincutaneousautoimmunebullousdisorders AT joshikusum utilityofdirectimmunofluorescenceincutaneousautoimmunebullousdisorders |